Induction of potent antitumor immunity by in situ targeting of intratumoral DCs
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Nonstandard abbreviations used: antigen (Ag); bone marrow (BM); CG-rich motif (CpG); complete medium (CM); control oligonucleotide (ODN-CTR); effector/target (E/T); Fms-like thyrosine kinase 3 ligand (Flt3L); Langerhans cell (LC); macrophage inflammatory protein-3α (MIP-3α); mean fluorescence intensity (MFI); T cell receptor (TCR).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A preclinical murine melanoma model showed increased migration of DCs in CCL20‐positive tumor cells, indicating the role of CCL20 in attracting DCs to the tumor site [368].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
T cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425
Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., & Bhardwaj, N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.233 · Cited by 1,359
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,246
Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K., & McKenna, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1953 · Cited by 1,115
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Research works printed but not linked: 3
- Gabrilovich, D.I., Corak, J., Ciernik, I.F., Kavanaugh, D., and Carbone, D.P. 1997. Decreased antigen pre- sentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3:483-490.
- Nestle, F.O., Burg, G., Fah, J., Wrone-Smith, T., and Nickoloff, B.J. 1997. Human sunlight-induced basal- cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am. J. Pathol. 150:641-651.
- Chen, K., et al. 1997. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res. 57:3511-3516.
Cited by
Items 101–200 of 235
Immunotherapy for liver tumors: present status and future prospects
Matar, P., Alaniz, L. D., Rozados, V. R., Aquino, J. B., Malvicini, M., Atorrasagasti, C., Gidekel, M., Silva, M., Scharovsky, O. G., & Mazzolini, G. D. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-30 · Cited by 32
Burn, O. K., Prasit, K., & Hermans, I. F. (2020) · Cancers · doi:10.3390/cancers12123824 · Cited by 31
Saito, T., Takayama, T., Osaki, T., Nagai, S., Suzuki, T., Sato, M., Kuwano, H., & Tahara, H. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00907.x · Cited by 31
Mir, F. A., Kaufmann, S. H. E., & Eddine, A. N. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00237-09 · Cited by 31
Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines
Ahlers, J. D., & Belyakov, I. M. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.04.003 · Cited by 31
Chi, W.-Y., Hu, Y., Huang, H., Kuo, H., Lin, S., Kuo, C.-T. J., Tao, J., Fan, D., Huang, Y.-M., Wu, A. A., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01082-x · Cited by 30
Rossi, A. H., Farias, A., Fernández, J. E., Bonomi, H. R., Goldbaum, F. A., & Berguer, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126827 · Cited by 30
Breaking Tolerance to Tumors with Dendritic Cell‐Based Immunotherapy
Mende, I., & Engleman, E. G. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1359.018 · Cited by 28
Self-citationZhao, D.-X., Li, Z., Zhang, Y., Zhang, X., Zhao, K.-C., Li, Y., Zhang, M., Yu, X., Liu, M.-Y., & Li, Y. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.03.020 · Cited by 27
Yan, W.-L., Wu, C.-C., Shen, K., & Liu, S. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002758 · Cited by 27
Ye, J., Qi, W.-X., Liu, M., & Li, Y. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.06.002 · Cited by 26
Potentiation of a Dendritic Cell Vaccine for Murine Renal Cell Carcinoma by CpG Oligonucleotides
Chagnon, F., Tanguay, S., Özdal, Ö. L., Guan, M., Özen, Z., Ripeau, J., Chevrette, M., ELHILALI, M. M., & Thompson-Snipes, L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1302.11.3 · Cited by 25
DC-based cancer vaccines: lessons from clinical trials
Brody, J., & Engleman, E. G. (2004) · Cytotherapy · doi:10.1080/14653240410005267 · Cited by 25
Self-citationZhang, X., Zhang, M., Cui, H., Zhang, T., Zhang, Z., Li, J., Zhou, J., Jiang, X., Liu, C., & Gao, J. (2024) · Small Structures · doi:10.1002/sstr.202400028 · Cited by 24
Sabado, R. L., Meseck, M. L., & Bhardwaj, N. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3387-7_44 · Cited by 24
Molecular Approaches To Target GPCRs in Cancer Therapy
Innamorati, G., Valenti, M. T., Giovinazzo, F., Carbonare, L. D., Parenti, M. D., & Bassi, C. (2011) · Pharmaceuticals · doi:10.3390/ph4040567 · Cited by 24
Utilizing TH9 cells as a novel therapeutic strategy for malignancies
Lu, Y., & Yi, Q. (2013) · OncoImmunology · doi:10.4161/onci.23084 · Cited by 24
Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma
Alshamsan, A. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.625034 · Cited by 24
Srivastava, R. M., Varalakshmi, C., & Khar, A. (2007) · International Immunology · doi:10.1093/intimm/dxm024 · Cited by 24
In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
Castiello, L., Aricò, E., D'Agostino, G., Santodonato, L., & Belardelli, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02303 · Cited by 23
Xu, Y., Darcy, P. K., & Kershaw, M. H. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701073 · Cited by 23
Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells
Wei, H., Wang, H., Lü, B., Li, B., Hou, S., Qian, W., Fan, K., Dai, J., Zhao, J., & Guo, Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6051 · Cited by 22
Raaijmakers, T. K., van den Bijgaart, R. J. E., den Brok, M. H., Wassink, M., de Graaf, A. M. A., Wagenaars, J. A. L., Nierkens, S., Ansems, M., Scheffer, G. J., & Adema, G. J. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000649 · Cited by 21
Oligonucleotide delivery in cancer therapy
Rosa, G. D., Stefano, D. D., & Galeone, A. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.527942 · Cited by 21
Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy
Tosch, C., Geist, M., Ledoux, C., Ziller-Remi, C., Paul, S., Erbs, P., Corvaïa, N., von Hoegen, P., Balloul, J.-M., & Haegel, H. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.85 · Cited by 21
Weigel, B. J., Panoskaltsis‐Mortari, A., Diers, M. D., García, M. M., Lees, C. J., Krieg, A. Μ., Chen, W., & Blazar, B. R. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.05.011 · Cited by 21
Cimetidine Induces Interleukin-18 Production through H2-Agonist Activity in Monocytes
Takahashi, H. K., Watanabe, T., Yokoyama, A., Iwagaki, H., Yoshino, T., Tanaka, N., & Nishibori, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025890 · Cited by 21
Sutherland, A. E., Mirjolet, J.-F., Maho, A., & Parmentier, M. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701074 · Cited by 20
Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells
Capobianco, A., Rovere, P. Q., Rugarli, C., & Manfredi, A. A. (2006) · International Journal of Cancer · doi:10.1002/ijc.22279 · Cited by 19
Mastini, C., Becker, P. D., Iezzi, M., Curcio, C., Musiani, P., Forni, G., Cavallo, F., & Guzmán, C. A. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908784293604 · Cited by 19
Gene expression profiles of nasal polyps associated with allergic rhinitis
Wu, J., Liu, B., He, J., & Fan, J. (2008) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2008.01.003 · Cited by 19
Lee, J. S., Kim, J. W., Choi, C. H., Lee, W. K., Chung, H. Y., & Lee, J. C. (2008) · The Journal of Microbiology · doi:10.1007/s12275-008-0052-z · Cited by 17
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
Kaufman, H. L., & Wolchok, J. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8 · Cited by 18
Using Signaling Pathways to Overcome Immune Tolerance to Tumors
Engleman, E. G., Brody, J., & Soares, L. R. B. (2004) · Science s STKE · doi:10.1126/stke.2412004pe28 · Cited by 17
Self-citationYanik, S. A., Venkatesh, V., Gordy, J. T., Alameh, M., Meza, J., Li, Y., Glass, E., Flores-García, Y., Tam, Y. K., Chaiyawong, N., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01089-x · Cited by 14
Maito, F. L. D. M., de Souza, A. P. D., Pereira, L., Smithey, M. J., Hinrichs, D. J., Bouwer, A., & Bonorino, C. (2012) · ISRN Immunology · doi:10.5402/2012/926817 · Cited by 14
Capobianco, A., Manfredi, A. A., Monno, A., Rovere, P. Q., & Rugarli, C. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318174a512 · Cited by 14
Rani, S. V., Babu, A., Sankari, S., Balachander, N., Malathi, L., & Masthan, M. K. (2015) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.166120 · Cited by 14
Application of DNA-based hydrogels as drug delivery system for immunomodulatory therapy
Cai, L., Mao, J., Wang, H., Chen, G., Xu, X.-L., Yuan, Q., & Chen, W. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104677 · Cited by 13
Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia
Westers, T. M., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.01.005 · Cited by 13
Microencapsulation of tumor lysates and live cell engineering with MIP-3α as an effective vaccine
Huang, F., Huang, F., Chen, B., Liu, Q., Wang, H., Zhou, S., Zhao, H., Huang, Y., Lin, Y., & Tan, G. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.123 · Cited by 12
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models
Clappaert, E. J., Kancheva, D., Brughmans, J., Debraekeleer, A., Bardet, P. M. R., Elkrim, Y., Lacroix, D., Živalj, M., Hamouda, A. E. I., Ginderachter, J. A. V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166180 · Cited by 12
Srivastava, R. M., Varalakshmi, C., & Khar, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.1117 · Cited by 12
van Bruggen, I., Nelson, D. J., Currie, A. J., Jackaman, C., & Robinson, B. W. S. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000170361.37832.ec · Cited by 12
FLT3L-induced virtual memory CD8 T cells engage the immune system against tumors
Tu, H.-F., Kung, Y.-J., Lim, L., Tao, J., Hu, M., Cheng, M., Xing, D., Wu, T. ‐., & Hung, C. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01006-9 · Cited by 11
Xu, X., Zeng, Z., Yao, W., Wang, X., Sun, D., Ka, W., Zhang, Y., Wang, X., Chen, X., Zha, Y., et al. (2010) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2010.04.028 · Cited by 11
The role of Langerhans cells in oral squamous cell carcinoma
Upadhyay, R. B., Upadhyay, J., Rao, N. N., & Agrawal, P. B. (2011) · The Chinese-German Journal of Clinical Oncology · doi:10.1007/s10330-011-0846-z · Cited by 11
Dendritic Cells in Alcoholic Liver Injury and Fibrosis
Aloman, C., Friedman, S. L., & Mérad, M. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01397.x · Cited by 12
Galili, U. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/134020 · Cited by 11
Wu, Z., Yang, Y., Li, J., Bossier, P., Wei, X., Guo, Z., Han, B., & Ye, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1243358 · Cited by 10
More than chemotaxis: A new anti-tumor DC vaccine modified by rAAV2-SLC
Liang, C., Ye, S., Zhong, C., Zheng, N., Bian, W., Sun, R., Chen, J., Li, R., Zhou, S. Y., & Liu, Y. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.03.026 · Cited by 10
Tepel, J., Dagvadorj, O., Kapischke, M., Sipos, B., Leins, A., Kremer, B., & Kalthoff, H. (2005) · International Journal of Colorectal Disease · doi:10.1007/s00384-005-0013-5 · Cited by 10
Yonenaga, Y., Mori, A., Fujimoto, A., Nagayama, S., Tachibana, T., Onodera, H., & Üemoto, S. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1013 · Cited by 10
van de Loosdrecht, A. A., van den Ancker, W., Houtenbos, I., Ossenkoppele, G. J., & Westers, T. M. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-71029-5_15 · Cited by 9
Effect of Flt3 ligand gene transfer in experimental pancreatic cancer
Ryschich, E., Huszty, G., Wentzensen, N., Schmidt, E., Knaebel, H. P., Encke, J., Märten, A., Büchler, M. W., & Schmidt, J. (2006) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0118-5 · Cited by 9
Choi, Y. J., & Kim, C. W. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01704.x · Cited by 8
Cerkovnik, P., Novaković, B. J., Stegel, V., & Novaković, S. (2009) · Innate Immunity · doi:10.1177/1753425909105581 · Cited by 8
The role of molecular imaging in the development of dendritic cell-based cancer vaccines
Lucignani, G., & Rescigno, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1858-0 · Cited by 8
Adenovirus-mediated CCL20/IL-15 gene transfer enhances antitumor immunity in mice
Liu, G., Jia, Q.-Y., Li, Z., Li, Y., Zhang, M., Liu, M., Wang, X., & Li, Y. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.02.009 · Cited by 7
CpG oligodeoxynucleotides as vaccine adjuvants
McCluskie, M. J., & Weeratna, R. D. (2006) · Elsevier eBooks · doi:10.1016/b978-012088403-2/50006-x · Cited by 7
Cytokine and chemokine networks in colorectal cancer
Zhang, X., Zhang, Y., & Wang, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1822271 · Cited by 6
Lemke-Miltner, C. D., Graham, J. B., Lubaroff, D. M., & Salem, A. K. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2010.57 · Cited by 6
Mechanisms of action of dendritic cell vaccines for the treatment of cancer
Zhang, C., & Engleman, E. G. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.06.008 · Cited by 6
Self-citationStegel, V., Kopitar, A. N., Novaković, B. J., Ihan, A., & Novaković, S. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.07.014 · Cited by 6
Breaking Self-Tolerance to Tumor-Associated Antigens by In Vivo Manipulation of Dendritic Cells
Mende, I., & Engleman, E. G. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-395-0_29 · Cited by 6
Self-citationShin, H.-S., Kim, H., Kwon, S. H., Lee, H., Lee, J., & Kim, Y. S. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100175 · Cited by 5
Toll-Like Receptor Pathway and its Targeting in Treatment of Cancers
Aalaei‐Andabili, S. H., Basith, S., Choi, S., & Rezaei, N. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_17 · Cited by 5
Tumor-Infiltrating Dendritic Cells: The Pathologist’s Perspective
Gutkin, D. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4_3 · Cited by 5
Xu, Q., Zhu, Y., Wang, H., Gong, Z.-W., & Yu, Y. (2016) · Biologicals · doi:10.1016/j.biologicals.2016.04.008 · Cited by 5
Personalizing DNA Cancer Vaccines
Wu, A. A., Peng, K., Vukovich, M., Zhu, M., Lin, Y., Bagga, A., Wu, T. ‐., & Hung, C. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15100474 · Cited by 4
Xiong, Z., Kong, Q., Chagantipati, B., Stepniak, A. L., Jaswal, A. P., Sneiderman, C. T., Han, Y., Jackson, S. A., Raphael, R. A., Zhang, W., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01360-0 · Cited by 4
Potential use of CpG ODN for cancer immunotherapy
Weeratna, R. D., Davis, H. L., Medynski, L., & Krieg, A. Μ. (2006) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2006.04.002 · Cited by 4
Lu, J., Zhang, Q., Liang, C., Xia, S., Zhong, C., & Wang, D. (2008) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2008.00431.x · Cited by 4
Cancer Immunotherapy by Anti-Gal-Mediated In Situ Conversion of Tumors Into Autologous Vaccines
Galili, U. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-813362-0.00010-5 · Cited by 4
Therapeutic Strategies for Targeting Mononuclear Phagocytes in Cancer
Dickens, D. S., & Jubinsky, P. T. (2008) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31816e236a · Cited by 4
Chemokines and chemokine receptors: the key regulators of tumor microenvironment
He, H., Yang, P., & Gao, Y. (2026) · Immunity & Inflammation · doi:10.1007/s44466-026-00038-0 · Cited by 3
Arab, S., Mojarrad, M., Motamedi, M., Mirzaei, R., Modarressi, M. H., & Hadjati, J. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12058 · Cited by 3
Dendritic cell-based immunotherapy: A promising approach for treatment of cancer
Murugaiyan, G., Basak, S. K., & Saha, B. (2005) · Cited by 3
Aspord, C., Charles, J., Leccia, M. ‐., Laurin, D., Richard, M., Chaperot, L., & Plumas, J. (2011) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.07.017 · Cited by 3
Targeting Colon Drug Delivery by Natural Products
Kim, H. (2012) · InTech eBooks · doi:10.5772/52346 · Cited by 2
Hammerich, L., & Brody, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-29827-6_6 · Cited by 2
Adams, S., Bhardwaj, N., & O’Neill, D. W. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_11 · Cited by 2
Fadeel, B. (2005) · Springer eBooks · doi:10.1007/1-4020-3302-8_3 · Cited by 2
Coukos, G., & Conejo-Garcia, J. R. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:285 · Cited by 2
Toll-Like Receptor Pathway and Its Targeting in Treatment of Cancers
Aalaei‐Andabili, S. H., Amini, N., Delavari, F., Keshavarz‐Fathi, M., Basith, S., Choi, S., & Rezaei, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_16 · Cited by 1
Bacteria in cancer therapy: Strategies to improvement and future directions
Naghavi, N. S., Ghiasian, M., & Samieipour, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820528-0.00013-2 · Cited by 1
Vadovičová, K. (2024) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/fwhak · Cited by 1
Vadovičová, K. (2025) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/fwhak_v2 · Cited by 1
Vadovičová, K. (2023) · arXiv (Cornell University) · doi:10.13140/rg.2.2.29677.97766 · Cited by 1
The Use of Human Dendritic Cell Subsets in Cancer Vaccines
Sweere, J. M. (2011) · Utrecht University Repository (Utrecht University)
Siachoque, H., Ibáñez‐Pinilla, M., Chuaire, L., García, O., Guzmán, A., & Flórez, L. (2005) · Revista Ciencias de la Salud
Les cellules dendritiques plasmacytoïdes dans le cancer à travers le rôle de TRAIL
Blum, A. (2007) · HAL
Ativação de células dendríticas na geração de células T CD8+ e T CD4+ anti-tumorais de memória
Maito, F. L. D. M. (2008) · Americanae (AECID Library)
COMBINATIONAL CYTOKINE THERAPY OF CANCER: PLEIOTROPIC IMPACT WITHIN THE TUMOR MICROENVIRONMENT
Berhanu, A. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
In situ tumor destruction: towards in vivo modulation of immune responses by dendritic cells.
den Brok, M. H. M. G. M. (2006) · Radboud Repository (Radboud University)
THE REGULATION OF DENRITIC CELL FUNCTION IN AUTOIMMUNE PRONE AND WILD TYPE MICE
Flores, R. R. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Choi, Y. J., Jeon, Y. H., Paik, J. H., Ko, J., Choi, D. H., Chung, J. K., & Kim, C. W. (2010) · Molecular Imaging · doi:10.2310/7290.2010.00010
Gautheron, A. (2015) · theses.fr (ABES) · doi:10.70675/1b60a990z1015z4f47z8c2fz84a6b408d4f1
Du protéome à l'immunopeptome : le modèle SIMP/STT3-B
Caron, É. (2004) · doi:10.71781/28437
Metadata
- Authors
- Furumoto, K., Soares, L., Engleman, E. G., & Merad, M.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Engleman, Edgar G.
- ORCID
- Engleman, Edgar G.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-03-01
- Volume
- 113
- Issue
- 5
- Pages
- 774-783
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4238827986
- Cited by
- 180
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 6 · 2014: 4 · 2013: 6 · 2012: 6
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- antitumor immunity, dendritic cells, cancer immunotherapy, Langerhans cells, macrophage inflammatory protein-3α, Flt3 ligand, CpG oligodeoxynucleotides, T cell activation, tumor-associated macrophages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.